Welcome to BGI International
Advancing Genomics for a Healthier World
Who We Are
Founded in 1999 as a nonprofit research organization, BGI International has grown into one of the world’s leading life science and genomics companies. With over 5,000 dedicated employees working in R&D, manufacturing, and commercial operations across the globe, BGI remains committed to improving global health outcomes and advancing scientific discovery.
Our journey started with a mission: to make genomics accessible and impactful for all. Today, BGI stands at the forefront of genomic innovation, empowering groundbreaking research in human health, agriculture, and environmental sustainability.
Our Core Expertise
At BGI, we specialize in delivering advanced solutions for the following key sectors:
Human Genomics
Genomics isn’t just about humans.
We decode the genomes of plants, animals, and ecosystems to build a more sustainable planet.
- Crop yield optimization
- Livestock disease resistance
- Biodiversity monitoring
- Soil and microbiome analysis
→ See our impact on agriculture and the environment
Public Health
At BGI, innovation isn’t just a goal it’s our DNA.
We develop and manufacture some of the world’s most advanced sequencing technologies, and we design and build world-class sequencing technologies to make genomic research faster, more accurate, and more accessible than ever before. From population-scale genome projects to precision diagnostics in the clinic, our technologies are trusted by scientists, clinicians, and governments worldwide.
DNBSEQ™ :
Ultra-Accurate, High-Throughput Sequencing
DNBSEQ™ (DNA Nanoball Sequencing) is BGI’s flagship next-generation sequencing (NGS) technology.
With its unique DNA nanoball (DNB) amplification and patterned array system, DNBSEQ™ offers:
- High accuracy with ultra-low error rates
- Massive scalability for large projects (population genomics, cancer screening)
- Reduced duplication and bias for better variant calling
- Flexible read lengths and throughput options
💡 Use cases: Whole-genome sequencing (WGS), transcriptomics, epigenomics, metagenomics.
,
MGISEQ™ Series :
Versatile Solutions for Labs & Clinics
he MGISEQ™ product line brings flexibility and performance to research and clinical environments. These platforms are engineered for:
- Routine genetic testing
- Targeted sequencing panels
- RNA sequencing and single-cell workflows
With user-friendly software and compact hardware, MGISEQ™ devices are ideal for medium-to-large laboratories needing reliable, efficient sequencing.
🔧 Models include:
- MGISEQ-2000: Mid-to-high throughput
- MGISEQ-T7: Ultra-high throughput, up to 60 human genomes/day
STOmics :
Spatial Transcriptomics for Complex Tissues
STOmics enables researchers to visualize gene expression in tissue samples with spatial resolution.
It combines NGS with high-resolution imaging, making it possible to study:
- Tumor microenvironments
- Neurobiology and brain architecture
- Organ development
- Cell–cell interaction networks
This technology bridges histology and genomics — unlocking spatial biology at unprecedented detail.
MassARRAY® System :
Fast, Cost-Efficient Genotyping
MassARRAY® is a mass spectrometry-based platform for high-throughput SNP genotyping, methylation analysis, and somatic mutation detection.
- Simple, PCR-based workflows
- Highly cost-effective for large sample sets
- Results in hours, not days
- Ideal for biobanks, population studies, and pharmacogenomics
🔬 Widely used in precision medicine, forensic analysis, and veterinary genetics.
At BGI, we provide a comprehensive portfolio of validated and regulatory-compliant genetic testing kits designed for clinical laboratories, hospitals, fertility centers, and research institutions.
Our genetic tests combine precision, speed, and clinical reliability, helping healthcare providers deliver faster diagnoses, personalized treatments, and better outcomes for patients worldwide.
All test kits are developed under strict quality control, conforming to CE-IVD, FDA (EUA), and ISO 13485 standards ensuring they meet the highest international regulations for in-vitro diagnostics.
Hereditary Disease Panels
Screen for genetic mutations associated with monogenic and inherited diseases, helping identify carriers, confirm diagnoses, and assess family risk.
- BRCA1/2 (breast & ovarian cancer susceptibility)
- Cystic fibrosis (CFTR gene)
- Thalassemia, sickle cell anemia
- Duchenne muscular dystrophy
- Familial hypercholesterolemia
💡 Ideal for: genetic counseling, family planning, early detection.
Oncology Genomic Panels
Identify somatic and germline mutations related to cancer development, treatment response, and prognosis.
- Lung cancer panel (EGFR, ALK, KRAS, ROS1…)
- Colorectal cancer (APC, TP53, MLH1…)
- Breast and ovarian cancer (BRCA1/2, PALB2, PTEN…)
- Pan-cancer panel: 500+ cancer-related genes
Prenatal & Neonatal Screening
Early detection of congenital conditions, chromosomal abnormalities, and inherited disorders in fetuses and newborns.
- Non-Invasive Prenatal Testing (NIPT) for trisomies 21, 18, 13
- Spinal muscular atrophy (SMA) screening
- Neonatal genetic disorder panels
- Congenital hearing loss mutations
🍼 Enable early interventions. Improve life-long outcomes.
Pharmacogenetics Panels
Predict individual drug response by testing genetic variants that influence drug metabolism, efficacy, and toxicity.
- CYP450 gene family (CYP2D6, CYP2C9, CYP3A5…)
- Warfarin sensitivity (VKORC1, CYP2C9)
- Statin response (SLCO1B1)
- Antidepressants and antipsychotics metabolism
⚕️ Optimize prescriptions. Reduce adverse drug reactions.
📈 Integrate precision medicine into everyday clinical practice.
Carrier Screening &Preimplantation Testing
Support reproductive decision-making with high-sensitivity screening for genetic disorders prior to or during pregnancy.
- Expanded carrier screening panels
- Preimplantation genetic testing for monogenic diseases (PGT-M)
- Chromosomal aneuploidy screening (PGT-A)
💑 Used in IVF clinics, fertility centers, and prenatal care units.
🧬 Reduce risks of transmitting genetic diseases to offspring.
At BGI, we know that reliable results start with reliable reagents. That’s why we offer a full line of high-quality reagents, enzymes, buffers, and consumables, precisely formulated and tested to support the most demanding molecular biology and genomics workflows.
Our reagents are compatible with BGI platforms (DNBSEQ™, MGISEQ™, etc.) as well as most third-party systems, making them ideal for research, diagnostics, and industrial labs seeking efficiency, consistency, and performance.
1 DNA & RNA Extraction
High-purity extraction kits optimized for a wide range of sample types:
- Whole blood, plasma, saliva, buccal swabs
- Tissue (fresh/frozen), FFPE samples
- Microorganisms (bacteria, viruses, fungi)
- Plants and environmental samples
✅ Rapid protocols
✅ High yield & integrity
✅ Automation-ready
2 Library Preparation & Amplification
Kits for preparing sequencing libraries with maximum efficiency and uniformity:
- DNA & RNA library prep kits (including low-input kits)
- Enzymes for fragmentation, end repair, A-tailing, ligation
- PCR-free kits for ultra-sensitive detection
- Index adapters and barcodes for multiplexing
🔧 Compatible with NGS platforms (DNBSEQ™, Illumina®, MGISEQ™…)
4 NGS Workflow Reagents
Boost performance and reduce costs in next-generation sequencing:
- Ultra-clean sequencing buffers and washes
- DNB synthesis kits
- Flow cell reagents
- Custom probe panels and enrichment reagents
4 Methylation & Epigenomics
Specialized kits for:
- Bisulfite conversion
- Methylation-specific PCR
- Chromatin immunoprecipitation (ChIP)
- Histone modification studies
Perfect for cancer epigenetics, developmental biology, and aging research.
4 qPCR, PCR, and RT-PCR Reagents
Fast and robust reagents for real-time and conventional PCR workflows:
- DNA/RNA polymerases with hot-start and proofreading capabilities
- One-step and two-step RT-PCR kits
- qPCR master mixes for SYBR® Green or TaqMan® assays
- Positive controls, primers, and probes
🎯 Clinical diagnostics
🧬 Gene expression
🔬 Pathogen detection
Global Reach
A Worldwide Impact
At BGI, our commitment to advancing genomics transcends borders. With operations spanning more than 100 countries, we bring cutting-edge technologies, services, and partnerships to communities and institutions around the world.
We believe that science should be accessible and impactful globally and we’ve built the infrastructure to make that happen.
- China : Headquarters and innovation hub
- United States : Clinical collaborations and research partnerships
- France : European genomics and education center
- Nigeria : Population health and infectious disease monitoring
- Brazil : Agricultural genomics and biodiversity initiatives